Skip to main content
. Author manuscript; available in PMC: 2007 Sep 15.
Published in final edited form as: Cancer Res. 2006 Sep 15;66(18):9299–9307. doi: 10.1158/0008-5472.CAN-06-1690

Table 1.

Effect of ATRA and IL-2 treatment on the number of white blood cells

Parameters Day 0 Before treatment Day 7 End of ATRA treatment Day 14 Before start of IL-2 Day 28 Two weeks of IL-2 Day 42 Four weeks of IL-2
WBC (× 106/ml) 6.22 ± 1.55 5.41 ± 1.53 p=0.07 6.71 ± 1.92 p=0.31 15.75 ± 6.32 p=0.01 10.01 ± 3.07 p=0.07
Neutrophils (× 106/ml) 3.99 ± 1.18 3.66 ± 1.49 p=0.14 4.50 ± 1.60 p=0.18 5.51 ± 2.64 p=0.02 3.06 ± 1.47 p=0.26
Lymphocytes (× 106/ml) 1.62 ± 0.52 1.47 ± 0.29 p=0.15 1.53 ± 0.68 p=0.85 4.40 ± 1.73 p=0.005 3.50 ± 1.40 p=0.001
Monocytes (× 106/ml) 0.58 ± 0.19 0.40 ± 0.15 p=0.04 0.53 ± 0.17 p=0.23 0.66 ± 0.52 p=0.73 0.57 ± 0.22 p=0.71

Eighteen patients were evaluated. Mean ± st. deviation are shown. P values were calculated using 2-sided Student’s t test. Each time point was compared with pre-treatment level (day 0).